As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...
While physicians may be exempt from the Trump administration’s new $100,000 fee for high-skilled H-1B visa applications, the threat of increased scrutiny on the visa program is making providers and ...
AI search is fundamentally changing how consumers navigate decision making, and brands must adapt in order to be discoverable.
The MarketWatch News Department was not involved in the creation of this content. BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- GATC Health, a leading tech-bio company leveraging artificial intelligence ...
Cosmos Health Inc. has announced its entry into the U.S. market and the launch of domestic manufacturing through a strategic agreement with DolCas Biotech LLC, a New Jersey-based developer of ...
Trinity Biotech launched CGM+, an AI-native wearable biosensor for glucose and multi-data monitoring, targeting the expanding healthcare market. Trinity Biotech plc, a biotechnology company ...
AbbVie has reportedly added Gilgamesh Pharmaceuticals to its shopping list. The Big Pharma teamed up with Gilgamesh last year and, according to Bloomberg, is now in talks about buying the mental ...
The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping takeover valuations, trailblazing innovation in battling obesity and cancer, ...
Hosted on MSN
I-Mab to buy Bridge Health Biotech
I-Mab (NASDAQ:IMAB) said on Thursday that it has signed an agreement to acquire Bridge Health Biotech. As part of the deal, I-Mab will provide an initial payment of $1.8M to Bridge Health shareholders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results